Inadequate Testing & Warnings
Unfortunately, the FDA does not always test these drugs thoroughly enough; other times the drugs might not have the appropriate warnings attached to them to let patients know the side effects.
What appears to be a miracle drug to cure one symptom can actually create a medical nightmare by causing other unintended complications. One example is the anti-obesity drug Fen-Phen, which may help you lose weight, but also has been shown to increase heart valve disease.
When a drug company puts out a medicine without doing enough research on the side effects then it is important to hold these multi-billion dollar makers liable for your pain.
Actos: Increased Risk for Bladder Cancer
Actos is a prescription medication commonly used to help control blood sugar levels in adults with Type II diabetes and is often prescribed as an alternative to the diabetes drug Avandia.
In June 2011, the FDA issued a safety warning linking Actos to an increased risk of bladder cancer. Analysis of results at the halfway point of a 10-year study showed the risk of bladder cancer increases as the duration and dose of the drug increases. Those that took Actos for more than one year had a 40% increased risk of developing bladder cancer.
The drug has been banned in some European countries; however, regulators in the US have not pulled the drug from store shelves, choosing to add information to the drug’s label to alert users of this potential risk.
Xarelto: No Proper Warnings about Uncontrollable Bleeding
Xarelto, a blood thinner prescribed by many doctors to prevent blood clots and protect patients from strokes, has a major safety flaw. Unlike its counterpart Warfarin, Xarelto has no antidote to reverse its blood-thinning effects, which can lead to irreversible internal bleeding problems in the brain, kidneys, lungs, and other organs, and ultimately end in death. Xarelto cannot be flushed out of one’s system; thus, the uncontrollable bleeding can be fatal.
In 2011, the FDA approved Xarelto’s use as a blood thinner for patients who have had knee or hip replacement surgery to reduce the risk of blood clots and for reducing the risk of stroke in people with an irregular heartbeat. It was also approved for the general treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE).
Testosterone Products under Investigation
Testosterone maintains many important bodily functions in men. Each year following the age of 30, testosterone levels begin to slowly decrease. For some, the levels drop so low (known as Low T) that it becomes a medical problem and requires a prescription to raise these levels.
However, the use of FDA-approved testosterone therapy has its risks such as an increased risk of stroke, heart attack, blood clots, and death.
- Confidential Settlement for Wrongful Death Suicide: While serving in the U.S. military in Afghanistan, client’s son committed suicide after having an adverse reaction to an anti-malaria drug.
Receive a Free Evaluation
To learn more about pharmaceutical drug injuries or to talk to an attorney about your situation, contact the law firm of Nash & Franciskato for your free, no-obligation case evaluation. Your health and future prospects may be at stake, and we want to help.